InvestorsHub Logo
Followers 0
Posts 109
Boards Moderated 0
Alias Born 04/15/2017

Re: None

Friday, 01/05/2018 2:59:19 PM

Friday, January 05, 2018 2:59:19 PM

Post# of 21544
Good news
Much better than I had expected. Farlow and Perry are the real deal and permitted themselves to be quoted. They will be first line therapy in moderate to severe Alzheimers - yes IV for now, but a depot or other delivery will be developed. Even if the drug is $100 million per year, the stock is undervalued. It will sell way more than $100 million a year.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SNPX News